Comera Life Sciences Holdings バランスシートの健全性
財務の健全性 基準チェック /26
Comera Life Sciences Holdings has a total shareholder equity of $102.3K and total debt of $389.9K, which brings its debt-to-equity ratio to 381.2%. Its total assets and total liabilities are $3.1M and $3.0M respectively.
主要情報
381.2%
負債資本比率
US$389.87k
負債
| インタレスト・カバレッジ・レシオ | n/a |
| 現金 | US$1.77m |
| エクイティ | US$102.26k |
| 負債合計 | US$2.97m |
| 総資産 | US$3.07m |
財務の健全性に関する最新情報
Recent updates
Comera Life Sciences rises on positive preclinical data from Sequrus study
Oct 18Comera life sciences expands woburn operations
Oct 04Comera Life Sciences announces up to $15M purchase agreement with Arena
Aug 31Comera Life Sciences GAAP EPS of -$1.14, revenue of $0.15M
Aug 10Comera Life Sciences Holdings (NASDAQ:CMRA) Is In A Good Position To Deliver On Growth Plans
May 27
財務状況分析
短期負債: CMRA's short term assets ($2.6M) do not cover its short term liabilities ($2.9M).
長期負債: CMRA's short term assets ($2.6M) exceed its long term liabilities ($37.3K).
デット・ツー・エクイティの歴史と分析
負債レベル: CMRA has more cash than its total debt.
負債の削減: Insufficient data to determine if CMRA's debt to equity ratio has reduced over the past 5 years.
貸借対照表
キャッシュ・ランウェイ分析
過去に平均して赤字であった企業については、少なくとも1年間のキャッシュ・ランウェイがあるかどうかを評価する。
安定したキャッシュランウェイ: Insufficient data to determine if CMRA has enough cash runway based on its current free cash flow.
キャッシュランウェイの予測: Insufficient data to determine if CMRA has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.